相关实验视频
Updated: Jul 10, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.5K
一个国际多利益相关者德尔菲调查研究疾病的设计修改帕金森病的疾病试验
Marie-Louise Zeissler1, Kevin McFarthing2, Karen G Raphael3,4
1Faculty of Health, University of Plymouth, Plymouth, UK.
Journal of Parkinson's disease
|November 26, 2023
概括
设计有效的帕金森病 (PD) 修改试验需要广泛的共识. 这项研究收集了全球利益相关者的意见,包括患有PD的人和护理伙伴,以确定试验设计和结果措施的优先事项.
科学领域:
- 神经科学是一个神经科学.
- 临床试验 临床试验
- 以患者为中心的研究
背景情况:
- 为帕金森病 (PD) 设计疾病修饰 (DM) 试验存在重大挑战.
- 成功的试验交付取决于不同利益相关者对优先事项和实际考虑的统一理解.
结论:
- 这项研究是关于帕金森病DM试验设计的首次系统性,多利益相关者商,结合了PwP和CP的关键观点.
- 这些发现提供了一个独特的利益相关者的观点库,指导开发更有效和以患者为中心的临床试验.
- 发现的分歧将有助于研究人员制定克服障碍的策略,并确保未来帕金森病修饰试验的成功实施.
相关概念视频
Parkinson's Disease: Treatment
276
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
276
Parkinson's Disease: Overview
557
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
557
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K

